These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25990800)

  • 1. S100B and ADMA in cerebral small vessel disease and cognitive dysfunction.
    Gao Q; Fan Y; Mu LY; Ma L; Song ZQ; Zhang YN
    J Neurol Sci; 2015 Jul; 354(1-2):27-32. PubMed ID: 25990800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric dimethylarginine in cerebral small vessel disease.
    Khan U; Hassan A; Vallance P; Markus HS
    Stroke; 2007 Feb; 38(2):411-3. PubMed ID: 17204687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between serum S100β protein levels and cognitive dysfunction in patients with cerebral small vessel disease: a case-control study.
    Wang F; Zou ZR; Yuan D; Gong Y; Zhang L; Chen X; Sun T; Yu HL
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28143956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease.
    Janes F; Cifù A; Pessa ME; Domenis R; Gigli GL; Sanvilli N; Nilo A; Garbo R; Curcio F; Giacomello R; Fabris M; Valente M
    Sci Rep; 2019 Oct; 9(1):14207. PubMed ID: 31578412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline predictors of cognitive decline in patients with cerebral small vessel disease.
    Pavlovic AM; Pekmezovic T; Tomic G; Trajkovic JZ; Sternic N
    J Alzheimers Dis; 2014; 42 Suppl 3():S37-43. PubMed ID: 24898641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline characteristic of patients presenting with lacunar stroke and cerebral small vessel disease may predict future development of depression.
    Pavlovic AM; Pekmezovic T; Zidverc Trajkovic J; Svabic Medjedovic T; Veselinovic N; Radojicic A; Mijajlovic M; Tomic G; Jovanovic Z; Norton M; Sternic N
    Int J Geriatr Psychiatry; 2016 Jan; 31(1):58-65. PubMed ID: 25821003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. l-Arginine Pathway Metabolites Predict Need for Intra-operative Shunt During Carotid Endarterectomy.
    Szabo P; Lantos J; Nagy L; Keki S; Volgyi E; Menyhei G; Illes Z; Molnar T
    Eur J Vasc Endovasc Surg; 2016 Dec; 52(6):721-728. PubMed ID: 27839876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total cerebral small vessel disease score and cognitive performance in community-dwelling older adults. Results from the Atahualpa Project.
    Del Brutto VJ; Ortiz JG; Del Brutto OH; Mera RM; Zambrano M; Biller J
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):325-331. PubMed ID: 28548298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral microbleeds are related to subjective cognitive failures: the RUN DMC study.
    van Norden AG; van Uden IW; de Laat KF; Gons RA; Kessels RP; van Dijk EJ; de Leeuw FE
    Neurobiol Aging; 2013 Sep; 34(9):2225-30. PubMed ID: 23623602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum level of S100B as a marker of progression of vascular mild cognitive impairment into subcortical vascular dementia and therapy effectiveness].
    Levada OA; Traïlin AV
    Lik Sprava; 2012; (3-4):53-9. PubMed ID: 23356138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between cerebral microbleeds and S100B/RAGE in acute lacunar stroke patients.
    Xiao L; Sun W; Lan W; Xiong Y; Duan Z; Zhang Z; Fan W; Xu L; Xie X; Ma N; Ye R; Xu G; Liu X; Zhu W
    J Neurol Sci; 2014 May; 340(1-2):208-12. PubMed ID: 24656601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of ambulatory blood pressure variability on cerebral small vessel disease progression and cognitive decline in community-based elderly Japanese.
    Yamaguchi Y; Wada M; Sato H; Nagasawa H; Koyama S; Takahashi Y; Kawanami T; Kato T
    Am J Hypertens; 2014 Oct; 27(10):1257-67. PubMed ID: 24651635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, risk factors and consequences of cerebral small vessel diseases: data from three Asian countries.
    Hilal S; Mok V; Youn YC; Wong A; Ikram MK; Chen CL
    J Neurol Neurosurg Psychiatry; 2017 Aug; 88(8):669-674. PubMed ID: 28600443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma asymmetric dimethylarginine is associated with cognitive deficits in patients with schizophrenia.
    Yang YJ; Xiong JW; Zhao Y; Zhan JQ; Chen HB; Yan K; Hu MR; Yu B; Wei B
    Psychiatry Res; 2016 Dec; 246():480-484. PubMed ID: 27794276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased total homocysteine level is associated with clinical status and severity of white matter changes in symptomatic patients with subcortical small vessel disease.
    Pavlovic AM; Pekmezovic T; Obrenovic R; Novakovic I; Tomic G; Mijajlovic M; Sternic N
    Clin Neurol Neurosurg; 2011 Nov; 113(9):711-5. PubMed ID: 21802199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric dimethylarginine (ADMA) and soluble vascular cell adhesion molecule 1(sVCAM-1) as circulating markers for endothelial dysfunction in patients with pheochromocytoma.
    Vasilev V; Matrozova J; Elenkova A; Vandeva S; Kirilov G; Zacharieva S
    Exp Clin Endocrinol Diabetes; 2013 Oct; 121(9):551-5. PubMed ID: 24002898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral microbleeds and cognition in patients with symptomatic small vessel disease.
    Patel B; Lawrence AJ; Chung AW; Rich P; Mackinnon AD; Morris RG; Barrick TR; Markus HS
    Stroke; 2013 Feb; 44(2):356-61. PubMed ID: 23321452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of serum S100B are associated with cognitive dysfunction in patients with type 2 diabetes.
    Yu H; Li H; Liu X; Du X; Deng B
    Aging (Albany NY); 2020 Feb; 12(5):4193-4203. PubMed ID: 32112645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease.
    Arlt S; Schulze F; Eichenlaub M; Maas R; Lehmbeck JT; Schwedhelm E; Jahn H; Böger RH
    Dement Geriatr Cogn Disord; 2008; 26(1):58-64. PubMed ID: 18617736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma beta-amyloid 1-40 is associated with the diffuse small vessel disease subtype.
    Gomis M; Sobrino T; Ois A; Millán M; Rodríguez-Campello A; Pérez de la Ossa N; Rodríguez-González R; Jiménez-Conde J; Cuadrado-Godia E; Roquer J; Dávalos A
    Stroke; 2009 Oct; 40(10):3197-201. PubMed ID: 19696416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.